genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • wound care
      Circadian Rhythm

      Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

      AI
      Antibodies

      AI-Based Strategy Boosts High-Affinity Antibody Drug Discovery

      Artificial intelligence
      Artificial Intelligence

      BenchSci Launches AI Tool to Map Disease Biology for Preclinical Drug…

      Diabetes

      Type 1 Diabetes May Be Treatable with Immunological Drug

      cancer vaccine
      Cancer

      Remodeling How Cancer Vaccines Are Designed

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      blood cells
      Blood Disorders

      Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Genome Editing

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Genome Editing

      Cell and Gene Therapy Scale-Up Challenges

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Topics Genome Editing Page 9

Genome Editing

  • CRISPR-Cas9
  • Gene Therapy
  • Synthetic Biology
    7 days popular
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Genome Editing

    Programming Language Automates Generation of Plug-and-Play DNA

    Alliance will enable technology improvements and better efficiencies.
    Genome Editing

    DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from...

    Genome Editing

    Lonza Opens Cell and Gene Therapy Facility in Pearland, TX

    Genome Editing

    Women in Science Video Project: Synthetic Biology Research

    Genome Editing

    Miltenyi Acquires Gene Therapy Assets from Lentigen

    Benitec Biopharma could generate up to $655 million-plus in payments from licensing its preclinical gene therapy for oculopharyngeal muscular dystrophy (OPMD; pictured)
    Genome Editing

    Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders

    1...789Page 9 of 9

    Recently Featured

    Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

    Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

    AI-Based Strategy Boosts High-Affinity Antibody Drug Discovery

    AI-Based Strategy Boosts High-Affinity Antibody Drug Discovery

    Type 1 Diabetes May Be Treatable with Immunological Drug

    Type 1 Diabetes May Be Treatable with Immunological Drug

    Remodeling How Cancer Vaccines Are Designed

    Remodeling How Cancer Vaccines Are Designed

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up